LAVAL, QC, Aug. 28 /CNW Telbec/ - ALERT B&C Corporation (the
"Corporation") (TSX Venture Exchange: ACB) today issued its consolidated
financial results for the three-month period ended June 30, 2007.
General and administrative expenses and commercialization and market
development costs amounted to $320,503 in the third quarter of 2007, compared
to $209,842 for the same quarter last year. This increase is due primarily to
legal and consulting fees related to the development of the BioDefence
operations. For the nine-month period ended June 30, 2007, these costs
amounted to $737,497 compared to $638,657 for the same period last year. Net
loss for the third quarter of fiscal 2007 was $351,356 ($0.01 per share)
compared to $250,963 ($0.01 per share) for the same period last year. For the
nine-month period ended June 30, 2007, the net loss amounted to $804,435
($0.02 per share) compared to $670,578 ($0.02 per share) for the same period
last year. On June 30, 2007, the Corporation had cash and cash equivalents of
$2,214,284 compared to $11,256 at the end of the last fiscal year ended
September 30, 2006.
As at June 30, 2007 there were 48,353,860 common shares outstanding.
About ALERT B&C
Founded in 1995, ALERT B&C is a BioDefence company dedicated to supplying
the BioDefence market with high quality technologies, products and solutions,
in order to improve and maintain the safety and the security of individuals
worldwide. For more information about the Corporation visit our website at
The Canadian Venture Exchange does not accept responsibility for the
adequacy or accuracy of this press release.
For further information:
For further information: Investor relations: Dr. Suzanne L. Lebel,
Chairman, President & CEO, ALERT B&C Corporation, (450) 688-4499, Fax : (450)
688-9100, email@example.com; Media Relations: Jean-Pierre Trudel, President, JP
Trudel & Associates Inc., (514) 347-6111, Fax: (514) 693-1253,